Pathological complete response in breast cancer.

  title={Pathological complete response in breast cancer.},
  author={Alberto Oca{\~n}a and Bo{\vs}tjan {\vS}eruga and Eitan Amir},
  volume={385 9963},
} Vol 385 January 10, 2015 113 Pathological complete response could better predict survival for women with hormone-receptor-negative breast cancer and with HER2-positive breast cancer treated with HER2 antagonists, but does not predict long-term outcome for hormone-positive or histologically low-grade tumours. These findings warrant stratification of the survival analysis by hormone receptors expressed and HER2 status. In the GEPARDUO study and the NSABP B-27 trial (both… CONTINUE READING
40 Citations
4 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 40 extracted citations


Publications referenced by this paper.
Showing 1-4 of 4 references

Draft Guidance for Industry . Pathologic complete response in neoadjuvant treatment of high - risk early - stage breast cancer : use as an endpoint to support accelerated approval

  • G vonMinckwitz, G Raab, A Caputo

Similar Papers

Loading similar papers…